(c) 2024 PillSync.com

methadone hydrochloride tablet

1 INDICATIONS AND USAGE Methadone hydrochloride tablets, USP are indicated for the: 1. Management of severe and persistent pain that requires an extended treatment period with a daily opioid analgesic for which alternative treatment options are inadequate. Limitations of Use • Because of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosage or duration [see Warnings and Precautions (5.1) ] , reserve methadone hydrochloride tablets for use in patients for whom alternative analgesic treatment options (e.g., non-opioid analgesics or opioid combination products) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. • Methadone hydrochloride tablets are not indicated as an as-needed (prn) analgesic. 2. Detoxification treatment of opioid addiction (heroin or other morphine-like drugs). 3. Maintenance treatment of opioid addiction (heroin or other morphine-like drugs), in conjunction with appropriate social and medical services. Limitations of Use • Methadone products used for the treatment of opioid addiction in detoxification or maintenance programs are subject to the conditions for distribution and use required under 42 CFR 8.12 [see Dosage and Administration (2.1)] . 1. Methadone hydrochloride tablets, USP are indicated for the management of severe and persistent pain that requires an extended treatment period with a daily opioid analgesic and for which alternative treatment options are inadequate. ( 1 ) Limitations of Use • Because of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosage or duration, and because of the greater risks of overdose and death with extended-release/long-acting opioid, reserve methadone hydrochloride tablets, USP for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or opioid combination products) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. ( 1 ) • Methadone hydrochloride tablets, USP are not indicated as an as-needed (prn) analgesic. ( 1 ) 2. Detoxification treatment of opioid addiction (heroin or other morphine-like drugs). 3. Maintenance treatment of opioid addiction (heroin or other morphine-like drugs), in conjunction with appropriate social and medical services.( 1 ) Limitations of Use • Methadone products used for the treatment of opioid addiction in detoxification or maintenance programs are subject to the conditions for distribution and use required under 42 CFR 8.12 ( 2.1 ).

epic pharma, llc


6 years ago ROUND WHITE E 318 methadone hydrochloride tablet

ROUND WHITE E 318

16 HOW SUPPLIED/STORAGE AND HANDLING Methadone Hydrochloride Tablets, USP 5 mg are white to off-white, round flat-faced beveled-edge tablets, debossed “Є” above "317" on one side and bisect on the other side. They are supplied as follows: Bottles of 100 (NDC 42806-317-01) Methadone Hydrochloride Tablets, USP 10 mg are white to off-white, round biconvex tablets, debossed “Є” above "318" on one side and bisect on the other side. They are supplied as follows: Bottles of 100 (NDC 42806-318-01) Store at 20° to 25°C (68° to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP/NF. Store methadone hydrochloride tablets securely and dispose of properly [see Patient Counseling Information (17) ].


More pills like ROUND E 318

Related Pills












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site